Displaying drugs 9776 - 9800 of 12591 in total
Dynorphin
Dynorphin is under investigation in clinical trial NCT00000244 (Effects of Dynorphin 1-13 on Heroin Addiction - 1).
Investigational
Matched Iupac: … hexanamido]-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid …
Matched Description: … Dynorphin is under investigation in clinical trial NCT00000244 (Effects of Dynorphin 1-13 on Heroin Addiction …
Matched Description: … Dynorphin is under investigation in clinical trial NCT00000244 (Effects of Dynorphin 1-13 on Heroin Addiction …
Idraparinux
Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X. It was developed for the treatment and prevention of thromboembolic events. However, clinical trials have revealed that idraparinux had lead to bleeding. As a result, Sanofi stopped the development of the drug.
Investigational
Matched Iupac: … dimethoxy-3-{[(2R,3R,4S,5R,6R)-3,4,5-trimethoxy-6-[(sulfooxy)methyl]oxan-2-yl]oxy}oxane-2-carboxylic acid …
Matched Description: … As a result, Sanofi stopped the development of the drug. ... It was developed for the treatment and prevention of thromboembolic events. ... Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X …
Matched Description: … As a result, Sanofi stopped the development of the drug. ... It was developed for the treatment and prevention of thromboembolic events. ... Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X …
5,6-Cyclic-Tetrahydropteridine
Experimental
Choline alfoscerate
A component of phosphatidylcholines (lecithins), in which the two hydroxy groups of glycerol are esterified with fatty acids. (From Stedman, 26th ed) It counteracts the effects of urea on enzymes and other macromolecules. [PubChem]
Experimental
Investigational
Matched Description: … A component of phosphatidylcholines (lecithins), in which the two hydroxy groups of glycerol are esterified ... (From Stedman, 26th ed) It counteracts the effects of urea on enzymes and other macromolecules. …
Rimeporide
Rimeporide has been used in trials studying the treatment of Muscular Dystrophy, Duchenne.
Investigational
Matched Description: … Rimeporide has been used in trials studying the treatment of Muscular Dystrophy, Duchenne. …
Cariporide
Investigational
Dexetimide
A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide.
Withdrawn
Matched Description: … Benzetimide is the (-)-enantimorph of dexetimide. …
Delpazolid
Delpazolid (LCB01-0371) is under investigation in clinical trial NCT01554995 (A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study).
Investigational
3'-Deazo-Thiamin Diphosphate
Experimental
N-acetylserotonin
Experimental
Nocodazole
Nocodazole is an antineoplastic agent which exerts its effect by depolymerizing microtubules.
Experimental
Sulfaquinoxaline
Sulfaquinoxaline is a veterinary medicine which can be given to cattle and sheep to treat coccidiosis.It is available in Pakistan with Sanna Laboratories in combination with Amprolium and Vitamin K as potential treatment of coccidiosis.
Vet approved
Matched Description: … Pakistan with Sanna Laboratories in combination with Amprolium and Vitamin K as potential treatment of …
Imidocarb
Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia and other parasites.
Vet approved
Matched Description: … Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of …
Nifenazone
Experimental
6'-Methyl-Thiamin Diphosphate
Experimental
PSI-352938
PSI-352938 has been used in trials studying the treatment of Hepatitis C and Hepatitis C, Chronic.
Investigational
Matched Description: … PSI-352938 has been used in trials studying the treatment of Hepatitis C and Hepatitis C, Chronic. …
Mercaptomethyl Phosphonate
Experimental
Acadesine
Acadesine (AICA-riboside) is a purine nucleoside analog with anti-ischemic properties that is currently being studied (Phase 3) for the prevention of adverse cardiovascular outcomes in patients undergoing coronary artery bypass graft (CABG) surgery. It is being developed jointly by PeriCor and Schering-Plough. Acadesine has been granted Orphan Drug Designation for...
Investigational
Matched Description: … nucleoside analog with anti-ischemic properties that is currently being studied (Phase 3) for the prevention of …
Displaying drugs 9776 - 9800 of 12591 in total